786 related articles for article (PubMed ID: 10830746)
1. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease.
Nishi J; Arimura K; Utsunomiya A; Yonezawa S; Kawakami K; Maeno N; Ijichi O; Ikarimoto N; Nakata M; Kitajima I; Fukushige T; Takamatsu H; Miyata K; Maruyama I
Br J Haematol; 1999 Mar; 104(3):482-5. PubMed ID: 10086783
[TBL] [Abstract][Full Text] [Related]
3. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
4. Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?
O'Leary J; Kennedy M; Howells D; Silva I; Uhlmann V; Luttich K; Biddolph S; Lucas S; Russell J; Bermingham N; O'Donovan M; Ring M; Kenny C; Sweeney M; Sheils O; Martin C; Picton S; Gatter K
Mol Pathol; 2000 Apr; 53(2):69-76. PubMed ID: 10889905
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6.
Aoki Y; Jaffe ES; Chang Y; Jones K; Teruya-Feldstein J; Moore PS; Tosato G
Blood; 1999 Jun; 93(12):4034-43. PubMed ID: 10361100
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma herpesvirus-associated Castleman's disease with POEMS syndrome.
Kim DE; Kim HJ; Kim YA; Lee KW
Muscle Nerve; 2000 Mar; 23(3):436-9. PubMed ID: 10679723
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic study of Castleman's disease in Korea.
Kim JE; Kim CJ; Park IA; Kim WH; Seo JW; Jang JJ; Kim CW; Park SH; Lee HS; Chi JG; Kim YI; Ham EK
J Korean Med Sci; 2000 Aug; 15(4):393-8. PubMed ID: 10983686
[TBL] [Abstract][Full Text] [Related]
8. Castleman's disease.
Palestro G; Turrini F; Pagano M; Chiusa L
Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
[TBL] [Abstract][Full Text] [Related]
9. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation.
Kang JG; Majerciak V; Uldrick TS; Wang X; Kruhlak M; Yarchoan R; Zheng ZM
J Pathol; 2011 Nov; 225(3):378-89. PubMed ID: 21984125
[TBL] [Abstract][Full Text] [Related]
11. Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with Castleman's disease.
Kikuta H; Itakura O; Taneichi K; Kohno M
Br J Haematol; 1997 Dec; 99(4):790-3. PubMed ID: 9432023
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 8 and Epstein-Barr virus coinfection in localized Castleman disease during pregnancy.
Hernández JL; Gómez-Román J; Ramos-Estébanez C; Nan D; Martín-Oviedo J; Riancho JA; González-Macías J
Haematologica; 2005 Nov; 90 Suppl():ECR35. PubMed ID: 16266926
[TBL] [Abstract][Full Text] [Related]
13. Castleman's disease--a two compartment model of HHV8 infection.
Schulte KM; Talat N
Nat Rev Clin Oncol; 2010 Sep; 7(9):533-43. PubMed ID: 20603649
[TBL] [Abstract][Full Text] [Related]
14. Targeted inhibition of angiogenic factors in AIDS-related disorders.
Aoki Y; Tosato G
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
[TBL] [Abstract][Full Text] [Related]
15. Fifty years of multicentric Castleman's disease.
Waterston A; Bower M
Acta Oncol; 2004; 43(8):698-704. PubMed ID: 15764213
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease.
Foss HD; Araujo I; Demel G; Klotzbach H; Hummel M; Stein H
J Pathol; 1997 Sep; 183(1):44-50. PubMed ID: 9370946
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC
Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.
Yoshizaki K; Matsuda T; Nishimoto N; Kuritani T; Taeho L; Aozasa K; Nakahata T; Kawai H; Tagoh H; Komori T
Blood; 1989 Sep; 74(4):1360-7. PubMed ID: 2788466
[TBL] [Abstract][Full Text] [Related]
19. Dissolution of the lymphoid follicle is a feature of the HHV8+ variant of plasma cell Castleman's disease.
Amin HM; Medeiros LJ; Manning JT; Jones D
Am J Surg Pathol; 2003 Jan; 27(1):91-100. PubMed ID: 12502931
[TBL] [Abstract][Full Text] [Related]
20. An attractive relation of human herpesvirus-8 with multicentric Castleman's disease.
Katano H; Sata T
Intern Med; 1999 Mar; 38(3):221-2. PubMed ID: 10337928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
